Tocilizumab-anoh
- Product NDC
- 72606-051
- 11-digit product format
- 726060051
- Labeler code
- 72606
- Product ID
- 72606-051_bacf86b8-9d2f-45d2-9c35-4f619ea494aa
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tocilizumab
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Labeler
- CELLTRION USA, Inc.
- Application
- BLA761420
- Marketing category
- BLA
- Marketing start
- 2025-01-26
- Substance
- TOCILIZUMAB
- Active strength
- 162 mg/.9mL
- Pharmacologic classes
- Interleukin 6 Receptor Antagonists [MoA], Interleukin-6 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tocilizumab-anoh
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TOCILIZUMAB | 162 mg/.9mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | I031V2H011 |
| Rxcui | 2705425, 2705435, 2705443, 2705450, 2705452 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72606-051-01 | Tocilizumab-anoh | 0.9 mL in 1 SYRINGE, GLASS | INJECTION, SOLUTION, CONCENTRATE | 0.9 | | 4 |
| 72606-051-01 | Tocilizumab-anoh | 1 in 1 CARTON | INJECTION, SOLUTION, CONCENTRATE | 1 | | 4 |
| 72606-051-02 | Tocilizumab-anoh | 0.9 mL in 1 SYRINGE, GLASS | INJECTION, SOLUTION, CONCENTRATE | 0.9 | | 4 |
| 72606-051-02 | Tocilizumab-anoh | 4 in 1 CARTON | INJECTION, SOLUTION, CONCENTRATE | 4 | | 4 |
| 72606-051-03 | Tocilizumab-anoh | 12 in 1 CARTON | INJECTION, SOLUTION, CONCENTRATE | 12 | | 4 |
| 72606-051-03 | Tocilizumab-anoh | 0.9 mL in 1 SYRINGE, GLASS | INJECTION, SOLUTION, CONCENTRATE | 0.9 | | 4 |
| 72606-051-04 | Tocilizumab-anoh | 0.9 mL in 1 SYRINGE, GLASS | INJECTION, SOLUTION, CONCENTRATE | 0.9 | | 4 |
| 72606-051-04 | Tocilizumab-anoh | 1 in 1 CARTON | INJECTION, SOLUTION, CONCENTRATE | 1 | | 4 |
| 72606-051-05 | Tocilizumab-anoh | 4 in 1 CARTON | INJECTION, SOLUTION, CONCENTRATE | 4 | | 4 |
| 72606-051-05 | Tocilizumab-anoh | 0.9 mL in 1 SYRINGE, GLASS | INJECTION, SOLUTION, CONCENTRATE | 0.9 | | 4 |
| 72606-051-06 | Tocilizumab-anoh | 12 in 1 CARTON | INJECTION, SOLUTION, CONCENTRATE | 12 | | 4 |
| 72606-051-06 | Tocilizumab-anoh | 0.9 mL in 1 SYRINGE, GLASS | INJECTION, SOLUTION, CONCENTRATE | 0.9 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72606-051 | TOCILIZUMAB-ANOH (TOCILIZUMAB) INJECTION, SOLUTION, CONCENTRATE [CELLTRION USA, INC.] | 2 | Current NDC, 12 package rows | 20250302_60381a7e-d7ae-4384-925d-c19c418d1663.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 72606-051-01 | 72606005101 | 1 SYRINGE, GLASS in 1 CARTON (72606-051-01) / .9 mL in 1 SYRINGE, GLASS | 2025-01-26 | No | No | Historical |
| 72606-051-02 | 72606005102 | 4 SYRINGE, GLASS in 1 CARTON (72606-051-02) / .9 mL in 1 SYRINGE, GLASS | 2025-01-26 | No | No | Historical |
| 72606-051-03 | 72606005103 | 12 SYRINGE, GLASS in 1 CARTON (72606-051-03) / .9 mL in 1 SYRINGE, GLASS | 2025-01-26 | No | No | Historical |
| 72606-051-04 | 72606005104 | 1 SYRINGE, GLASS in 1 CARTON (72606-051-04) / .9 mL in 1 SYRINGE, GLASS | 2025-01-26 | No | No | Historical |
| 72606-051-05 | 72606005105 | 4 SYRINGE, GLASS in 1 CARTON (72606-051-05) / .9 mL in 1 SYRINGE, GLASS | 2025-01-26 | No | No | Historical |
| 72606-051-06 | 72606005106 | 12 SYRINGE, GLASS in 1 CARTON (72606-051-06) / .9 mL in 1 SYRINGE, GLASS | 2025-01-26 | No | No | Historical |